1. Home
  2. CGEM vs AHG Comparison

CGEM vs AHG Comparison

Compare CGEM & AHG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cullinan Oncology Inc.

CGEM

Cullinan Oncology Inc.

N/A

Current Price

$19.60

Market Cap

1.1B

Sector

Health Care

ML Signal

N/A

AHG

Akso Health Group ADS

N/A

Current Price

$1.47

Market Cap

1.1B

ML Signal

N/A

Company Overview

Basic Information
Metric
CGEM
AHG
Founded
2016
2013
Country
United States
China
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Business Services
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
1.1B
1.1B
IPO Year
2020
2017

Fundamental Metrics

Financial Performance
Metric
CGEM
AHG
Price
$19.60
$1.47
Analyst Decision
Strong Buy
Analyst Count
8
0
Target Price
$30.13
N/A
AVG Volume (30 Days)
524.7K
6.8K
Earning Date
05-11-2026
08-14-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$5.20
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$5.68
$1.10
52 Week High
$19.82
$2.50

Technical Indicators

Market Signals
Indicator
CGEM
AHG
Relative Strength Index (RSI) 66.45 43.82
Support Level $11.87 $1.24
Resistance Level N/A $1.64
Average True Range (ATR) 0.99 0.11
MACD 0.20 -0.01
Stochastic Oscillator 93.11 37.15

Price Performance

Historical Comparison
CGEM
AHG

About CGEM Cullinan Oncology Inc.

Cullinan Therapeutics Inc is a clinical-stage biopharmaceutical company developing therapies for autoimmune diseases and cancer. Its development pipeline comprises the following drug candidates: CLN-978, a CD19xCD3 bispecific T cell engager that is being developed for autoimmune diseases; CLN-049, a FLT3xCD3 bispecific T cell engager being evaluated in an ongoing clinical trial in patients with relapsed/refractory acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS); Velinotamig, a BCMAxCD3 bispecific T cell engager being developed to counter autoimmune diseases; and Zipalertinib, being developed as a treatment for non-small cell lung cancer. Additionally, the company is developing several preclinical programs in autoimmune diseases and oncology.

About AHG Akso Health Group ADS

Akso Health Group is a social e-commerce platform based in China. The company collaborates with domestic e-commerce platforms and offers users a wide selection of high-quality and affordable products on its social e-commerce platform. It generates majority of the revenues from sale of medical devices business.

Share on Social Networks: